DMOT4039A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMOT4039A, covering 2017-01-10 to 2017-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer [Phase 1]